# FDA Inspection 1262276 - Alnylam Pharmaceuticals Inc. - February 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/f171eb1e-7893-4b06-a4b1-a428da24972b
Source feed: FDA_Inspections

> FDA Inspection 1262276 for Alnylam Pharmaceuticals Inc. on February 25, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262276
- Company Name: Alnylam Pharmaceuticals Inc.
- Inspection Date: 2025-02-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New England District Office

## Related Documents

- [FDA Inspection 1109687 - 2019-09-13](https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/9b61b3e9-b09f-4fb5-bd03-b0a13d279ae2)

Company: https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/285be436-d642-438b-ac4c-530088c678b8

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144